Skip to main content
Article thumbnail
Location of Repository

Preclinical evaluation and visualization of herpes simplex virus thymidine kinase/ganciclovir suicide gene therapy

By Ingrid Johanna van Dillen


Although substantial progress has been made in the struggle against cancer, new anti-tumor strategies are still needed. A candidate strategy is the use of a so-called 'suicide gene' in combination with a prodrug. To this end, the herpes simplex virus thymidine kinase (HSV-tk)/ganciclovir (GCV) suicide gene/prodrug system has been extensively studied over the past fifteen years in preclinical and clinical settings (1). ... Zie: Summary

Topics: Gentherapie, Proefschriften (vorm); medische genetica
Year: 2004
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.